Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Chris Hyungseop Han picked up the Award of Excellence at the 74th Annual International Magnesium Association (IMA) World Magnesium Conference held in Singapore last month.

Dr. Jan Guy (Immediate Past President, Executive Committee Member, Board of Directors of IMA) (left) Chris Hyungseop Han (right)

The IMA Awards of Excellence program, established in 1962, is an annual program open to all researchers and companies demonstrating outstanding examples of magnesium's use. Nominations are judged by a peer review panel of international experts and winners are recognised worldwide. 

Chris won the award of excellence for his research in the development of Biodegradable Magnesium Alloy for Orthopaedic Applications. 

Often a patient will need two parts of their bones screwed together, which then results in a second operation to have the screws removed. For the past 8 years, Chris has been a part of a research team that overcame these limitations and created a roadmap to the next generation of metallic biodegradable implant materials with completely biocompatible elements. A state of the art method to synchronise the corrosion potential was developed to control the corrosion rate. 

Working closely with major hospitals in Korea, the research team have performed several hundred cases of small bone fixation screws and the results have been promising. The BBC World News ‘Horizons’ programme recently featured the team’s research as a medical breakthrough.

Chris commented:

"I am deeply honoured to have received the award of excellence from IMA. I would like to thank my family, my supervisors (Dr James Edwards and Professor Sion Glyn-Jones), my mentors at Korea Institute of Science and Technology (Dr. Hyun-Kwang Seok and Dr. Yu-Chan Kim) and the U&I Corporation for their support over the years. I am hoping to collaborate with more professionals at Oxford to explore the new possibilities of these biodegradable metallic materials." 

 

clinical Trial Published Clinical Trial Published on PNAS

Similar stories

Oxford-Bristol Myers Squibb Fellowships awarded to NDORMS researchers

Six researchers from the Botnar Research Centre and the Kennedy Institute of Rheumatology at NDORMS have been awarded fellowships as part of the Oxford-Bristol Myers Squibb Fellowship Programme, providing them an opportunity to gain exposure to the field of commercial drug discovery and development.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

NDORMS researchers join new multidisciplinary oncology research project

OPTIMA aims to improve treatment for patients with prostate, breast and lung cancer through artificial intelligence

Professor David Beard awarded BOA Honorary Fellowship

Professor of Musculoskeletal and Surgical Science, David Beard, has been awarded an Honorary Fellowship by the British Orthopaedic Association.

Farewell to Angela, NDORMS Head of Administration

Angela Truesdale, who has retired from her role as Head of Administration at NDORMS will be fondly missed by all her colleagues and across the division.

Antonella Delmestri selected as a Fellow of the Alan Turing Institute

NDORMS Lead Health Data Scientist, Antonella Delmestri, has been selected as a Fellow of the Alan Turing Institute.